Plan B GAO Investigation Sought By House Members
This article was originally published in The Pink Sheet Daily
Executive Summary
Group led by Rep. Waxman is requesting that GAO examine communications between the White House and HHS regarding FDA's decision not to approve the Plan B emergency contraceptive switch application.
You may also be interested in...
FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
The New York Democrat seeks a Senate Health Committee oversight hearing and General Accounting Office investigation as part of full review of FDA’s rejection of OTC status for the emergency contraceptive.
FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
The New York Democrat seeks a Senate Health Committee oversight hearing and General Accounting Office investigation as part of full review of FDA’s rejection of OTC status for the emergency contraceptive.
Advisory Committee Member Viewpoints On Meeting Topics Should Be Part Of Vetting Process, GAO Says
Collecting information on committee member viewpoints ensures independence and impartiality in public eye, GAO report states. Committee nominees should be asked about public statements, participation in legal proceedings, previous research, GAO adds.